A3384

· Albireo

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for A3384, covering 2024-03-07 to 2024-03-07. Get the full timeline:

Most recent: Clinical Trial Update: Double-blind, Randomised Study of A3384 in BAM/BAD [Phase 2]